Search Results - "Gyotoku, H" :: K.UTB vyhledávací portál

1924P Efficacy and safety of lenvatinib in patients with chemotherapy-naive advanced or recurrent thymic carcinoma: A multicenter retrospective study

by Hazama, D., Takagi, K., Saito, G., Tsugitomi, R., Ashinuma, H., Shukuya, T., Gyotoku, H., Sakata, S., Mouri, A., Miwa, H., Tamura, Y., Tokito, T., Tsukita, Y., Kogure, Y., Masuda, T., Tanaka, H., Kubo, S., Suzuki, T.
Published in Annals of oncology (01.09.2024)

Get full text

Journal Article

Loading…

316P Phase II study of ramucirumab and docetaxel for platinum-resistance NSCLC patients with malignant pleural effusion: Analysis of pleural effusion control rate

by Ogata, R., Takemoto, S., Fukuda, M., Senju, H., Nakatomi, K., Sugasaki, N., Tomono, H., Suyama, T., Shimada, M., Akagi, K., Hayashi, F., Dotsu, Y., Taniguchi, H., Gyotoku, H., Yamaguchi, H., Nagashima, S., Soda, H., Kinoshita, A., Mukae, H.
Published in Annals of oncology (01.11.2022)

Get full text

Journal Article

Loading…

1015P Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1 negative or weakly positive advanced non-small cell lung cancer after disease progression on platinum-based therapy: WJOG10317L study (EMERALD)

by Zenke, Y., Niho, S., Nakamura, A., Okamoto, T., Hara, S., Akazawa, Y., Hosomi, Y., Hayashi, H., Teraoka, S., Yokoyama, T., Ozaki, T., Ueno, K., Gyotoku, H., Misumi, T., Nakagawa, K., Yamamoto, N., Tsuboi, M.
Published in Annals of oncology (01.09.2022)

Get full text

Journal Article

Loading…

EP08.04-005 Phase II Study of Ramucirumab and Docetaxel for NSCLC Patients with Malignant Pleural Effusion

by Takemoto, S., Fukuda, M., Senju, H., Nakatomi, K., Sugasaki, N., Ogata, R., Tomono, H., Suyama, T., Shimada, M., Akagi, K., Hayashi, F., Gyotoku, H., Yamaguchi, H., Nagashima, S., Soda, H., Kinoshita, A., Mukae, H.
Published in Journal of thoracic oncology (01.09.2022)

Get full text

Journal Article

Loading…

A retrospective analysis of patients with non-small cell lung cancer who developed drug-induced lung disorder by immune checkpoint inhibitors

by Hayashi, F., Taniguchi, H., Takayuki, S., Umeyama, Y., Dotsu, Y., Gyotoku, H., Senju, H., Takemoto, S., Yamaguchi, H., Ono, S., Tomono, H., Shimada, M., Soda, H., Fukuda, M., Hiroshi, M.
Published in Annals of oncology (01.11.2019)

Get full text

Journal Article

Loading…

A retrospective analysis of immune checkpoint therapy in patients with non-small cell lung cancer: Focus on thyroid disorder

by Ono, S., Senju, H., Taniguchi, H., Tomono, H., Shimada, M., Hayashi, F., Suyama, T., Honda, N., Umeyama, Y., Dotsu, Y., Gyotoku, H., Takemoto, S., Yamaguchi, H., Fukuda, M., Soda, H., Mukae, H.
Published in Annals of oncology (01.11.2019)

Get full text

Journal Article

Loading…

P1.03-015 The Relationship between the UGT1A127 and UGT1A17 Genetic Polymorphisms and Irinotecan-Related Toxicities in Patients with Lung Cancer

by Fukuda, M., Okumura, M., Arimori, K., Takahira, A., Mori, M., Nakamura, D., Shimada, M., Taniguchi, H., Gyotoku, H., Senju, H., Ikeda, T., Yamaguchi, H., Nakatomi, K., Tsuchiya, T., Mukae, H., Ashizawa, K.
Published in Journal of thoracic oncology (01.11.2017)

Get full text

Journal Article